Cannell & Spears’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $96M | Buy |
798,223
+452,283
| +131% | +$52.2M | 1.88% | 11 |
|
|
2025
Q4 | $36.4M | Buy |
345,940
+648
| +0.2% | +$60.8K | 0.68% | 40 |
|
|
2025
Q3 | $29M | Buy |
345,292
+7,934
| +2% | +$653K | 0.55% | 53 |
|
|
2025
Q2 | $26.7M | Buy |
337,358
+2,301
| +0.7% | +$183K | 0.54% | 58 |
|
|
2025
Q1 | $30.1M | Buy |
335,057
+7,260
| +2% | +$678K | 0.65% | 48 |
|
|
2024
Q4 | $32.6M | Sell |
327,797
-1,142
| -0.3% | -$118K | 0.67% | 47 |
|
|
2024
Q3 | $37.4M | Buy |
328,939
+8,936
| +3% | +$1.06M | 0.74% | 44 |
|
|
2024
Q2 | $39.6M | Sell |
320,003
-6,737
| -2% | -$868K | 0.82% | 38 |
|
|
2024
Q1 | $43.1M | Buy |
326,740
+313,375
| +2,345% | +$38.6M | 0.89% | 37 |
|
|
2023
Q4 | $1.46M | Buy |
13,365
+496
| +4% | +$51.5K | 0.12% | 71 |
|
|
2023
Q3 | $1.32M | Sell |
12,869
-800
| -6% | -$86.2K | 0.11% | 71 |
|
|
2023
Q2 | $1.58M | Buy |
13,669
+946
| +7% | +$107K | 0.13% | 70 |
|
|
2023
Q1 | $1.35M | Buy |
12,723
+290
| +2% | +$31.3K | 0.12% | 79 |
|
|
2022
Q4 | $1.38M | Sell |
12,433
-200
| -2% | -$20.4K | 0.13% | 74 |
|
|
2022
Q3 | $1.09M | Hold |
12,633
| – | – | 0.11% | 84 |
|
|
2022
Q2 | $1.15M | Hold |
12,633
| – | – | 0.1% | 86 |
|
|
2022
Q1 | $1.04M | Sell |
12,633
-6,004
| -32% | -$473K | 0.08% | 100 |
|
|
2021
Q4 | $1.43M | Buy |
18,637
+6,079
| +48% | +$484K | 0.1% | 85 |
|
|
2021
Q3 | $943K | Sell |
12,558
-300
| -2% | -$22.8K | 0.07% | 100 |
|
|
2021
Q2 | $1M | Sell |
12,858
-360
| -3% | -$26.8K | 0.07% | 100 |
|
|
2021
Q1 | $972K | Sell |
13,218
-7,651
| -37% | -$564K | 0.08% | 94 |
|
|
2020
Q4 | $1.63M | Sell |
20,869
-5,292
| -20% | -$405K | 0.14% | 71 |
|
|
2020
Q3 | $2.07M | Hold |
26,161
| – | – | 0.2% | 61 |
|
|
2020
Q2 | $1.93M | Buy |
26,161
+21
| +0.1% | +$1.58K | 0.2% | 58 |
|
|
2020
Q1 | $1.92M | Sell |
26,140
-1,080
| -4% | -$84.9K | 0.23% | 58 |
|
|
2019
Q4 | $2.36M | Buy |
27,220
+1,339
| +5% | +$110K | 0.25% | 38 |
|
|
2019
Q3 | $2.08M | Hold |
25,881
| – | – | 0.24% | 38 |
|
|
2019
Q2 | $2.07M | Sell |
25,881
-2,222
| -8% | -$170K | 0.24% | 36 |
|
|
2019
Q1 | $2.23M | Sell |
28,103
-315
| -1% | -$23.6K | 0.28% | 38 |
|
|
2018
Q4 | $2.07M | Sell |
28,418
-122
| -0.4% | -$8.61K | 0.3% | 37 |
|
|
2018
Q3 | $1.93M | Sell |
28,540
-46
| -0.2% | -$2.93K | 0.23% | 40 |
|
|
2018
Q2 | $1.66M | Buy |
28,586
+116
| +0.4% | +$6.54K | 0.22% | 44 |
|
|
2018
Q1 | $1.48M | Hold |
28,470
| – | – | 0.19% | 44 |
|
|
2017
Q4 | $1.53M | Hold |
28,470
| – | – | 0.19% | 45 |
|
|
2017
Q3 | $1.74M | Buy |
28,470
+1,132
| +4% | +$68.6K | 0.21% | 45 |
|
|
2017
Q2 | $1.67M | Hold |
27,338
| – | – | 0.21% | 40 |
|
|
2017
Q1 | $1.66M | Buy |
27,338
+692
| +3% | +$42K | 0.21% | 42 |
|
|
2016
Q4 | $1.5M | Buy |
26,646
+115
| +0.4% | +$6.73K | 0.19% | 42 |
|
|
2016
Q3 | $1.58M | Hold |
26,531
| – | – | 0.2% | 41 |
|
|
2016
Q2 | $1.46M | Sell |
26,531
-210
| -0.8% | -$11.2K | 0.18% | 41 |
|
|
2016
Q1 | $1.35M | Sell |
26,741
-10,487
| -28% | -$514K | 0.16% | 46 |
|
|
2015
Q4 | $1.88M | Buy |
37,228
+6,253
| +20% | +$315K | 0.21% | 45 |
|
|
2015
Q3 | $1.46M | Buy |
30,975
+5,911
| +24% | +$314K | 0.17% | 54 |
|
|
2015
Q2 | $1.36M | Hold |
25,064
| – | – | 0.15% | 58 |
|
|
2015
Q1 | $1.38M | Buy |
25,064
+561
| +2% | +$31.8K | 0.16% | 56 |
|
|
2014
Q4 | $1.33M | Hold |
24,503
| – | – | 0.15% | 61 |
|
|
2014
Q3 | $1.39M | Buy |
24,503
+285
| +1% | +$16K | 0.17% | 53 |
|
|
2014
Q2 | $1.34M | Hold |
24,218
| – | – | 0.16% | 51 |
|
|
2014
Q1 | $1.31M | Hold |
24,218
| – | – | 0.16% | 47 |
|
|
2013
Q4 | $1.16M | Hold |
24,218
| – | – | 0.14% | 48 |
|
|
2013
Q3 | $1.1M | Hold |
24,218
| – | – | 0.14% | 50 |
|
|
2013
Q2 | $1.07M | Buy |
+24,218
| New | +$1.08M | 0.16% | 45 |
|
Other funds holding MRK
VCM
VPM
Cannell & Spears's MRK Position: Q1 2026 in Review
Cannell & Spears increased its Merck (MRK) stake by 131% in Q1 2026, buying an estimated $52.2M and bringing the position to 798,223 shares worth $96M. The position accounts for 1.88% of the portfolio, ranked #11.
Cannell & Spears first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Cannell & Spears held 798,223 shares of Merck worth $96M as of Q1 2026.
- Cannell & Spears bought 452,283 Merck shares in Q1 2026, an estimated $52.2M.
- Merck made up 1.88% of Cannell & Spears's portfolio in Q1 2026, its #11 holding.
- Cannell & Spears first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.